CCO Management Series
Understanding and Implementing the AASLD’s HBV Practice Guidelines and Other Recent Guidelines and Recommendations on the Diagnosis, Management, and Treatment of Hepatitis B
Interactive Virtual Presentations
Hepatitis B Screening, Diagnosis, and Treatment Candidacy
|
Program Director: W. Ray Kim, MD
- Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF
|
|
|
Watch, listen, and test your knowledge as Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, reviews the latest guideline recommendations on screening for and diagnosing hepatitis B virus infection and determining the need for treatment and/or follow-up after diagnosis.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply guideline recommendations and data on chronic hepatitis B prevalence to identify at-risk populations who should be screened and vaccinated for hepatitis B virus infection
- Interpret data from long-term follow-up studies investigating risk factors for progressive liver disease among patients with chronic hepatitis B
- Employ established diagnostic criteria to accurately determine disease phase in patients with hepatitis B virus infection
- Evaluate eligibility for chronic hepatitis B treatment based on expert guideline recommendations
- Propose optimal monitoring strategies for patients with chronic hepatitis B who are not considered to be candidates for therapy at initial diagnosis
|
Slideset: Hepatitis B Screening, Diagnosis, and Treatment Candidacy
 |
|
In this downloadable slideset, Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, reviews the latest guideline recommendations on HBV screening, diagnosis, and treatment candidacy.
Format: Microsoft PowerPoint (.ppt) |
File size: 5.78 MB
| Date posted: 11/11/2010
|
Using HBV Treatment Guidelines in Determining How to Treat
|
Program Director: W. Ray Kim, MD
- Nezam H. Afdhal, MD, FRCPI
|
|
|
In this Interactive Virtual Presentation, Nezam H. Afdhal, MD, FRCPI, provides an in-depth review of the most recent expert guidelines on the optimal treatment of patients with chronic HBV infection.
Learning Objectives
Upon completion of this activity, participants should be able to:
- List treatments recommended for management of chronic hepatitis B in HBV-infected patients
- Define the recommended duration of therapy for HBV-infected patients
- Describe strategies for changing treatment in HBV-infected patients with drug resistance
|
Slideset: Using HBV Treatment Guidelines in Determining How to Treat
 |
|
Join Nezam H. Afdhal, MD, FRCPI, as he outlines AASLD guidelines and offers practical information on treatment and monitoring of HBV-infected patients.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.70 MB
| Date posted: 12/2/2010
|
Interactive Case Challenges
Management of an HBeAg-Positive Korean American Male With Decompensated Cirrhosis
|
Program Director: W. Ray Kim, MD
|
|
Robert J. Fontana, MD, discusses the challenging management decisions involved in treating an HBV-infected patient with decompensated cirrhosis.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Evaluate the role of oral nucleos(t)ide analogues in the management of an HBV-infected patient with decompensated cirrhosis
- Define the recommended duration of therapy for HBV-infected patients with decompensated cirrhosis
- Design a strategy for distinguishing between therapeutic noncompliance and antiviral resistance
|
Management of an HBeAg-Positive Woman Wishing to Start a Family in the Near Term
|
Program Director: W. Ray Kim, MD
|
|
Robert G. Gish, MD, discusses optimal management strategies for an HBeAg-positive woman of childbearing age.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Employ the appropriate test to determine current HBV infection
- Compare and contrast the recommended anti-HBV agents for a woman of childbearing age
- Apply the appropriate time point at which to discontinue anti-HBV treatment in HBeAg-positive patients
|
Management of an HBeAg-Negative Chinese Patient
|
Program Director: W. Ray Kim, MD
|
|
Myron J. Tong, MD, PhD, reviews guideline recommendations and key factors to consider when managing an HBeAg-negative Chinese immigrant who is fearful of Western medicine.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply expert guideline recommendations when assessing the need for treatment in a patient with HBeAg-negative chronic HBV infection
- Construct first-line regimens for the treatment of chronic hepatitis B that incorporate guideline recommendations as well as patient preferences to optimize the likelihood of treatment success
- Propose treatment durations for patients initiating anti-HBV therapy according to regimen choice and disease characteristics
|
Partnership Information
|
|
|
This program is produced in collaboration with the AASLD. For more information about the AASLD, click on the following link.
To view the AASLD 2009 Practice Guidelines*, click on the following link.
*The AASLD 2009 Practice Guidelines were developed solely by AASLD without industry funding or influence. |
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by USF Health and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|